AzTrials
AzTrials

Fluid OverloadNCT05957003

Fluid Responsiveness in Post-cardiac Surgery

A study testing Combined end-expiratory occlusion and end-inspiratory occlusion test and Tidal volume challenge test in people with Fluid Overload and Cardiac Surgery, run by Tanta University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

the study aims to examine the validity of combined end-expiratory and end-inspiratory occlusion test and tidal volume challenge test for prediction of fluid responsiveness in immediate post-cardiac surgery patients Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Combined end-expiratory occlusion and end-inspiratory occlusion test and Tidal volume challenge test
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
90 participants
Where
1 siteEgypt
Study dates
10 Aug 2023to 1 Sep 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients on mechanical ventilation
  • Patients ≥18 years of age
  • patients undergoing cardiac surgery (coronary artery bypass graft, valve repair/ replacement, combined cardiac surgery)
  • patients with normal systolic function of the left and right ventricle
  • patient is mechanically ventilated with a protective lung strategy

Who cannot join

  • Patients with Spontaneously breathing activity
  • Patients undergoing emergent cardiac surgery.
  • Patient with severe peripheral arterial occlusive disease
  • Pregnant women
  • Contraindication of passive leg raising test
  • unstable post-operative course
Show all 10Show fewer
  • Post-operative complications such as uncontrolled bleeding, severe neurologic impairment, or accidental mechanical complications;
  • presence of residual severe tricuspid or any valvular regurgitations
  • low cardiac output, low ejection fractions (EF ≤45%)
  • open chest,Pao2/Fio2 ≤ 200

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Faculty of medicine, Tanta university

    Tanta, El Gharbyia, 31111

Other trials in Egypt

About this study

Official title: The Validity of Combined End-expiratory and End-inspiratory Occlusion Test and Tidal Volume Challenge Test for Prediction of Fluid Responsiveness in Immediate Post-cardiac Surgery Patients

the study aims to examine the validity of combined end-expiratory and end-inspiratory occlusion test and tidal volume challenge test for prediction of fluid responsiveness in immediate post-cardiac surgery patients

Read the detailed description

multiple studies prove that dynamic variables based on heart-lung interactions accurately can predict fluid responsiveness in mechanically ventilated patients, including pulse pressure variation (PPV) and stroke volume (SV) variation.

Furthermore, passive leg raising (PLR), end-expiratory occlusion test, and tidal volume challenge test, "Mini"-fluid challenge are currently available to assess fluid responsiveness.

Being tested
Combined end-expiratory occlusion and end-inspiratory occlusion test, Tidal volume challenge test
Medical subject headings
Edema, Postoperative Complications

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Combined end-expiratory occlusion and end-inspiratory occlusion testProcedure or surgery

    The EEO test will be performed by interrupting the mechanical ventilation at end-expiration over 15 seconds using the end-expiratory hold button available on the ventilator.

    The EIO test will be performed by interrupting the mechanical ventilation at end-inspiration over 15 seconds using the end-inspiratory hold button available on the ventilator.

  • Tidal volume challenge testProcedure or surgery

    elevating tidal volume from 6 ml/kg to 8 ml/kg for only 60 seconds

Study groups in NCT05957003
Study groupRoleWhat they receive
occlusions testActive comparatorCombined end expiratory (EEO) and inspiratory occlusion (EIO) test. A 15-s EEO separated by a time window of 1 minute to allow the hemodynamic parameters to return to baseline followed by a 15-s EIO
Receives: Procedure: Combined end-expiratory occlusion and end-inspiratory occlusion test
challenge testActive comparatorTidal volume (TV) challenge test (transient increase of TV from 6 to 8 mL/kg for 1 minute)
Receives: Procedure: Tidal volume challenge test

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The number of volume responder participants could be detected using each fluid responsiveness test

    The number of volume responder participants could be detected using each fluid responsiveness test including tidal volume challenge test and combined end-expiratory occlusion and end-inspiratory occlusion test

    Measured: immediate postoperative period

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Jul 2023
  2. Study start10 Aug 2023
  3. Primary completion20 Aug 2025
  4. Study completion1 Sep 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
90 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05957003
Sponsor's protocol ID
fluid responsiveness
Status last verified
Nov 2025
First submitted
14 Jul 2023
Last updated
25 Nov 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Combined end-expiratory occlusion and end-inspiratory occlusion test and Tidal volume challenge test in people with Fluid Overload and Cardiac Surgery, run by Tanta University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Nov 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The number of volume responder participants could be detected using each fluid responsiveness test (time frame: immediate postoperative period). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Nov 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in